Literature DB >> 10707961

Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.

E S Park1, H Kim, J M Suh, S J Park, O Y Kwon, Y K Kim, H K Ro, B Y Cho, J Chung, M Shong.   

Abstract

TSH has multiple physiological roles: it is required for growth, differentiation, and function of the thyroid gland, and it regulates transcription of interferon-gamma (IFN-gamma)-responsive genes in thyrocytes, including genes for the major histocompatibility complex and intercellular adhesion molecule-1. This report demonstrates that TSH induces the expression of suppressor of cytokine signaling (SOCS)-1 and -3 proteins and alters the phosphorylation state of signal transducer and activator of transcription (STAT) proteins STAT1 and STAT3. The expression of SOCS-1 and SOCS-3 and the phosphorylation state of STAT1 and STAT3 were examined after treatment with TSH or IFN-gamma in either TSH-sensitive FRTL-5 thyroid cells or TSH-insensitive FRT and buffalo rat liver (BRL) cells, which lack functional TSH receptors. SOCS-1 and SOCS-3 are constitutively expressed in FRTL-5 cells, but not in FRT and BRL cells. IFN-gamma up-regulated SOCS-1 and SOCS-3 RNA and protein in FRTL-5 cells, as reported previously for nonthyroid cells. Interestingly, TSH also significantly induced SOCS-1 and SOCS-3 in FRTL-5 cells, but not in FRT and BRL cells. When SOCS-1 or SOCS-3 was overexpressed in FRTL-5 cells, STAT1 phosphorylation at Y701 and STAT1/DNA complex formation in response to IFN-gamma were reduced. Furthermore, overexpression of either SOCS-1 or SOCS-3 significantly inhibited the IFN-gamma-mediated transactivation of the rat ICAM-1 (intercellular adhesion molecule-1) promoter. TSH and IFN-gamma had different effects on STAT1 and STAT3 phosphorylation. The phosphorylation of Y701 in STAT1, which is responsible for homodimer formation, nuclear translocation, and DNA binding, was specifically stimulated by IFN-gamma, but not by TSH or forskolin. However, the phosphorylation of S727 in STAT1 was induced by IFN-gamma, TSH, and forskolin. TSH induced phosphorylation of both Y705 and S727 in STAT3, while IFN-gamma phosphorylated only the Y705. In addition, we found that SOCS-3 was associated with JAK1 and JAK2 and that these associations were stimulated by TSH. These findings demonstrate that TSH induces SOCS in thyroid cells and provides the evidence of signal cross-talk between TSH and cytokines in thyroid cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10707961     DOI: 10.1210/mend.14.3.0433

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  15 in total

1.  SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues.

Authors:  Sungpil Yoon; Young-Su Yi; Sang Soo Kim; Ju-Hwa Kim; Won Sang Park; Suk Woo Nam
Journal:  Tumour Biol       Date:  2011-11-12

2.  Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells.

Authors:  William A Sands; Hayley D Woolson; Gillian R Milne; Claire Rutherford; Timothy M Palmer
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 3.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

4.  SOCS proteins in development and disease.

Authors:  Monique C Trengove; Alister C Ward
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

5.  Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism.

Authors:  Tomohiro Hori; Hidenori Ohnishi; Takahide Teramoto; Kohji Tsubouchi; Takafumi Naiki; Yoshinobu Hirose; Osamu Ohara; Mariko Seishima; Hideo Kaneko; Toshiyuki Fukao; Naomi Kondo
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

6.  Thyroid peroxidase autoantibodies are associated with a lesser likelihood of late reversion to hyperthyroidism after successful non-ablative treatment of Graves' disease in Croatian patients.

Authors:  M Stefanic; I Karner
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

7.  Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.

Authors:  Shanli Tsui; Vibha Naik; Neil Hoa; Catherine J Hwang; Nikoo F Afifiyan; Amiya Sinha Hikim; Andrew G Gianoukakis; Raymond S Douglas; Terry J Smith
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  Cell-type-specific expression of STAT transcription factors in tissue samples from patients with lymphocytic thyroiditis.

Authors:  Julia Staab; Peter J Barth; Thomas Meyer
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

Review 9.  Thyrotropin, Hyperthyroidism, and Bone Mass.

Authors:  Se-Min Kim; Vitaly Ryu; Sari Miyashita; Funda Korkmaz; Daria Lizneva; Sakshi Gera; Rauf Latif; Terry F Davies; Jameel Iqbal; Tony Yuen; Mone Zaidi
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 6.134

10.  Regulation of inhibitors of differentiation family proteins by thyroid-stimulating hormone in FRTL-5 thyroid cells.

Authors:  Young Suk Jo; Eun Suk Hwang; Ju Hee Lee; Yunhyeong Lee; Seul Young Kim; Yun-Sun Choi; Youn-Sun Bai; Jun Hwa Hong; Yun-Jeung Kim; Ihn-Suk Lee; So Young Rha; Heung-kyu Ro; Minho Shong
Journal:  J Korean Med Sci       Date:  2008-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.